Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Teva presents potential antipsoriatic agents

Feb. 12, 1997

Diagnostic MAbs from Terumo

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Eisai synthesizes heterocyclic anticancer compounds

Feb. 11, 1997

Hypoglycemic/hypolipidemic agents from Kyorin

Feb. 11, 1997

Takeda prepares NO production inhibitors

Feb. 11, 1997

Sankyo develops antidiabetic agents

Feb. 11, 1997

ET antagonists reported by Japanese investigators

Feb. 11, 1997

U.S. and European investigators describe agents for CNS disorders

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...